Subscribe To
Reneo pharmaceuticals: buy before upcoming pivotal data drop
Reneo Pharmaceuticals is developing mitochondrial disease therapies, with its lead program being mavode...
October 29, 2023, 8:00 pm
Reneo pharmaceuticals announces poster presentation at upcoming scientific meetings
IRVINE, Calif., Oct. 25, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...
October 25, 2023, 11:50 am
Clene to present at upcoming september conferences
SALT LAKE CITY, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary...
August 30, 2023, 8:20 am
Reneo pharmaceuticals to participate in upcoming investor conferences
IRVINE, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...
August 29, 2023, 11:35 am
Reneo pharmaceuticals to participate in svb securities therapeutics forum
IRVINE, Calif., June 30, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...
June 30, 2023, 12:25 pm
Genedx to present new data on urine mitochondrial dna testing at the 2023 united mitochondrial disease foundation’s mitochondrial medicine symposium
STAMFORD, Conn., June 28, 2023 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical...
June 28, 2023, 11:00 am
Reneo pharmaceuticals added to russell 2000® and russell 3000® indices
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused on the ...
June 26, 2023, 12:25 pm
Update — reneo pharmaceuticals to participate at the jefferies healthcare conference
IRVINE, Calif., May 31, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the d...
May 31, 2023, 2:38 pm
Cyclerion announces definitive agreement for zagociguat and cy3018
Certain Cyclerion shareholders and new investors have agreed to invest $81M to launch a new company targeting diseases of ...
May 11, 2023, 10:00 pm
Reneo announces pricing of public offering of common stock
IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (Reneo) (Nasdaq: RPHM), a clinical-stage pharmaceutical company focused ...
May 4, 2023, 3:36 am
Reneo pharmaceuticals to participate in svb securities global biopharma conference
IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) — Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...
February 2, 2023, 12:35 pm
Mayflower bioventures launches its first spin-out, primera therapeutics, in strategic collaboration with cellectis to develop a gene editing platform to treat mitochondrial diseases
NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Following the formation of Mayflower Bioventures, a cell and gene therapy accelerator stood up from Hibis...
December 29, 2022, 9:30 pm
Unicycive to participate in upcoming investor conferences
Highlights Late-Stage Program in Hyperphosphatemia and Early-Stage Program to Combat Diseases of mitochondrial...
November 28, 2022, 7:00 am
Reneo pharmaceuticals to participate at upcoming investor conferences
IRVINE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the ...
September 6, 2022, 8:35 am